Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.
Saved in:
| Title: | Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors. |
|---|---|
| Authors: | Magbanua MJM; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. mark.magbanua@ucsf.edu., Manon NA; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Wolf DM; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Rivero-Hinojosa S; Natera Inc., Austin, TX, USA., Ahmed Z; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Sayaman RW; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Tin A; Natera Inc., Austin, TX, USA., Renner D; Natera Inc., Austin, TX, USA., Kalashnikova E; Natera Inc., Austin, TX, USA., Brown-Swigart L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Hirst GL; Department of Surgery, University of California San Francisco, San Francisco, CA, USA., Yau C; Department of Surgery, University of California San Francisco, San Francisco, CA, USA., Li W; Department of Radiology, University of California San Francisco, San Francisco, CA, USA., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Shatsky RA; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Clark AS; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA., Zimmer A; Division of Hematology/Oncology, Oregon Health and Science University, Portland, OR, USA., Delson AL; Breast Science Advocacy Core, University of California San Francisco, San Francisco, CA, USA., Rodriguez A; Natera Inc., Austin, TX, USA., Liu MC; Natera Inc., Austin, TX, USA., Pohlmann PR; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Esserman LJ; Department of Surgery, University of California San Francisco, San Francisco, CA, USA., Rugo HS; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA., DeMichele A; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA., van 't Veer L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. |
| Source: | Nature communications [Nat Commun] 2025 Dec 09; Vol. 16 (1), pp. 9945. Date of Electronic Publication: 2025 Dec 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-65432-5 |
